Irish research identifies protein's role in prolonging cancer cell survival

Irish research published today has revealed a new target for future treatment of Hodgkin’s Lymphoma.

Irish research identifies protein's role in prolonging cancer cell survival

Irish research published today has revealed a new target for future treatment of Hodgkin’s Lymphoma.

The findings are the first indication that Bfl1 protein plays a crucial role in prolonging the survival of Hodgkin/Reed-Sternberg (HRS) cells, the malignant cell that is critical to tumour development.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

Lunchtime News

Newsletter

Keep up with stories of the day with our lunchtime news wrap and important breaking news alerts.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited